{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":57,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":57,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"bc6c5d71f5d0","filters":{"venue":"Drugs of today"}},"results":[{"id":"W2985958489","doi":"10.1358/dot.2019.55.10.3045038","title":"Viltolarsen for the treatment of Duchenne muscular dystrophy","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Dystrophin; Exon skipping; Exon; Medicine; Morpholino; RNA splicing; Muscular dystrophy; Alternative splicing; Bioinformatics; Genetics; Internal medicine; Gene; Gene knockdown; RNA; Biology","authors":[{"name":"Rohini Roy Roshmi","is_ca":true},{"name":"Toshifumi Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03020348874980639,"gpt":0.3216006072539669,"spread":0.2913971185041606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001907824,0.0005162155,0.0008082153,0.001478208,0.0001754982,0.0004379663,0.0005319123,0.0005862472,0.004290409],"category_scores_gemma":[0.0002131579,0.0001366819,0.0003594915,0.0008533392,0.0001844913,0.0004977913,0.0003245741,0.001332556,0.001893388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002771605,"about_ca_system_score_gemma":0.0003464942,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004258982,"about_ca_topic_score_gemma":0.001132265,"domain_scores_codex":[0.9999181,0.00001270574,0.0000133248,0.00001716711,0.00002917485,0.000009457696],"domain_scores_gemma":[0.9999335,0.00003009591,0.0000124285,0.00000188703,0.00001252453,0.000009616278],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001561001,0.00009947773,0.000119222,0.01116017,0.0001008042,0.0002889163,0.0000416981,0.0002043903,0.003871831,0.001392191,0.01718303,0.9653823],"study_design_scores_gemma":[0.00006974518,0.0002752652,0.001079367,0.001979032,0.0001594271,0.003021166,0.00003585534,0.00008614228,0.001640971,0.0007483301,0.9908878,0.00001683766],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005125579,0.9970067,0.000172956,0.0001838198,0.0001595482,0.000008088312,0.00003878837,0.00001849947,0.001899028],"genre_scores_gemma":[0.003192407,0.9943525,0.0002968449,0.0002824375,0.0001237883,0.00001233712,0.0001015267,0.000003982548,0.001634303],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004290409,"threshold_uncertainty_score":0.0143528,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3047556542","doi":"10.1358/dot.2020.56.8.3159186","title":"Golodirsen for Duchenne muscular dystrophy","year":2020,"lang":"en","type":"article","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Exon skipping; Duchenne muscular dystrophy; Exon; Medicine; Dystrophin; Morpholino; Muscular dystrophy; Gene; Bioinformatics; Genetics; Antisense therapy; Internal medicine; Gene knockdown; Biology; Oligonucleotide; Alternative splicing","authors":[{"name":"Saeed Anwar","is_ca":true},{"name":"Toshifumi Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0094307765891266,"gpt":0.2321511105201688,"spread":0.2227203339310422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003601206,0.0004207593,0.0004255757,0.0004497433,0.0002730443,0.0003886579,0.0002344255,0.0008307984,0.0106948],"category_scores_gemma":[0.0004039359,0.00005744219,0.0003641182,0.0002533626,0.0002324624,0.0003558146,0.0003645105,0.001442214,0.004190814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003979275,"about_ca_system_score_gemma":0.0003805268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002534201,"about_ca_topic_score_gemma":0.0008288745,"domain_scores_codex":[0.999858,0.00003652279,0.00001122601,0.00002417022,0.00004211701,0.00002800497],"domain_scores_gemma":[0.9998919,0.00002469575,0.00002373905,0.000005750759,0.00001872498,0.00003523372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003516761,0.0004588285,0.0009433018,0.001741699,0.000106891,0.00288773,0.0001360847,0.0002368906,0.02902093,0.01435986,0.1159532,0.8306379],"study_design_scores_gemma":[0.00124641,0.00270696,0.004028795,0.0004363744,0.00007560791,0.004920297,0.00004465809,0.0001191613,0.005893716,0.001824643,0.9786744,0.00002896981],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.09712142,0.6938637,0.005530341,0.05621586,0.009959509,0.0005850325,0.001924913,0.001572117,0.1332271],"genre_scores_gemma":[0.413173,0.2945254,0.01165019,0.04777746,0.005445892,0.0005432483,0.002970258,0.0002248252,0.2236897],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.0106948,"threshold_uncertainty_score":0.03577769,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2701201582","doi":"10.1358/dot.2017.53.5.2613690","title":"Brodalumab: The first anti-IL-17 receptor agent for psoriasis","year":2017,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Ixekizumab; Psoriasis Area and Severity Index; Psoriasis; Ustekinumab; Psoriatic arthritis; Dermatology; Interleukin 17; Clinical trial; Erythroderma; Immunology; Internal medicine; Adalimumab; Immune system; Disease","authors":[{"name":"L. Puig","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06135471088143997,"gpt":0.3181274239703031,"spread":0.2567727130888632,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004090101,0.0007321572,0.0006068725,0.0005216069,0.0003478382,0.0009108399,0.0005808054,0.001042925,0.007306969],"category_scores_gemma":[0.0004645211,0.0002069532,0.0005892211,0.0002152704,0.0002144434,0.0004429994,0.0004533847,0.002635266,0.006258456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000566823,"about_ca_system_score_gemma":0.0006205406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008537576,"about_ca_topic_score_gemma":0.002040497,"domain_scores_codex":[0.9997573,0.00003410981,0.00001459398,0.00003799328,0.00008807617,0.00006798818],"domain_scores_gemma":[0.9998096,0.00001940296,0.00002419087,0.00000946201,0.00005497455,0.00008248448],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002542682,0.0008323741,0.0009901704,0.001588547,0.0001865105,0.001255794,0.00008180101,0.0002893801,0.03486802,0.001664104,0.1474055,0.8082951],"study_design_scores_gemma":[0.002736715,0.003231919,0.003743277,0.0004611696,0.0001475347,0.003641265,0.00001551073,0.0003724772,0.01493353,0.0003226872,0.9703532,0.00004068579],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.09354915,0.7029866,0.01113346,0.01685652,0.0169618,0.002022784,0.006319543,0.004006501,0.1461636],"genre_scores_gemma":[0.4121186,0.3253724,0.02139258,0.03833162,0.005531207,0.001576383,0.01164087,0.0005460313,0.1834902],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007306969,"threshold_uncertainty_score":0.02444422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3161179238","doi":"10.1358/dot.2021.57.5.3264119","title":"Remimazolam: a short-acting benzodiazepine for procedural sedation","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Benzodiazepine; Sedation; Anesthesia; Internal medicine","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0334317832994494,"gpt":0.3167641908888383,"spread":0.2833324075893889,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002187639,0.0004388357,0.0002975017,0.0005818254,0.0002202411,0.0003072772,0.0004426938,0.0004482968,0.002872626],"category_scores_gemma":[0.0002520814,0.00009991354,0.0002861136,0.0002625946,0.0002590068,0.0003944978,0.0003837713,0.0008801545,0.002104287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003238478,"about_ca_system_score_gemma":0.000408786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004061681,"about_ca_topic_score_gemma":0.0007322403,"domain_scores_codex":[0.9998222,0.00003690149,0.00002334768,0.00002354853,0.00006264918,0.0000313003],"domain_scores_gemma":[0.9998971,0.0000091763,0.00003160932,0.000005093494,0.00002946793,0.00002753104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008327344,0.000321266,0.000883556,0.002337425,0.00005904943,0.001975002,0.0001225631,0.0003010454,0.2993089,0.00530747,0.01517989,0.673371],"study_design_scores_gemma":[0.0004539691,0.004890489,0.009181411,0.0006033482,0.00009411694,0.03722073,0.00009085637,0.001012702,0.2023368,0.001757031,0.7422543,0.0001042216],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1807,0.6399166,0.08161872,0.009139273,0.003441429,0.0007123462,0.001417057,0.002902648,0.08015195],"genre_scores_gemma":[0.6350567,0.2399148,0.05461748,0.005074836,0.001830711,0.0003909796,0.001712516,0.0002193271,0.06118254],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002872626,"threshold_uncertainty_score":0.009609878,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968779439","doi":"10.1358/dot.2005.41.4.908565","title":"Statin-associated neuromyotoxicity","year":2005,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Geranylgeranyl pyrophosphate; Myopathy; Rhabdomyolysis; Statin; Mevalonate pathway; Disease; Bioinformatics; Internal medicine; Prenylation; Biochemistry; Biology","authors":[{"name":"Steven K. Baker","is_ca":true},{"name":"Mark A. Tarnopolsky","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01048578839546409,"gpt":0.259453654406713,"spread":0.2489678660112489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000235136,0.0002569998,0.0002950283,0.0004046058,0.0004417236,0.0003087272,0.0001553668,0.0005882398,0.003319338],"category_scores_gemma":[0.0007920061,0.00009557162,0.0002794279,0.0004776585,0.0002631846,0.0002088801,0.0005253304,0.0004297317,0.0008992459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005194158,"about_ca_system_score_gemma":0.0004660306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001598225,"about_ca_topic_score_gemma":0.002471606,"domain_scores_codex":[0.9997585,0.00004747215,0.00004331016,0.00003339701,0.00006243906,0.00005487312],"domain_scores_gemma":[0.9996037,0.00004804317,0.0001928472,0.00003503581,0.00005341672,0.0000671052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002663246,0.0003010183,0.2823301,0.001855156,0.0005290032,0.1945734,0.0005216394,0.0004846363,0.04747485,0.004402434,0.01077351,0.454091],"study_design_scores_gemma":[0.0001452051,0.001156745,0.4599736,0.0007023889,0.0003632414,0.4452438,0.0003816954,0.0009060327,0.01118671,0.003558962,0.07632726,0.00005438322],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"editorial","genre_scores_codex":[0.8399438,0.1094334,0.0021498,0.004858505,0.0002937779,0.0002341431,0.0009545574,0.0002006689,0.04193134],"genre_scores_gemma":[0.9678031,0.02453673,0.0006685856,0.001898767,0.0002542842,0.00003629634,0.0002827459,0.00001430019,0.004505232],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.003319338,"threshold_uncertainty_score":0.01110423,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045159955","doi":"10.1358/dot.2004.40.5.850489","title":"Levocetirizine: A new selective H1 receptor antagonist for use inallergic disorders","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Levocetirizine; Cetirizine; Medicine; Pharmacology; Histamine; Histamine H1 receptor; Antagonist; Pharmacokinetics; Receptor; Internal medicine","authors":[{"name":"James H. Day","is_ca":true},{"name":"Anne K. Ellis","is_ca":false},{"name":"Elizabeth Rafeiro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03495536806048386,"gpt":0.3191909200766362,"spread":0.2842355520161523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002343227,0.0007735706,0.0011704,0.002150911,0.0002611355,0.0006332397,0.0006902355,0.0006704045,0.004195324],"category_scores_gemma":[0.0002430798,0.000179211,0.0003177232,0.002134338,0.0002697858,0.0008116192,0.0003586997,0.0009620878,0.002534223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003857178,"about_ca_system_score_gemma":0.0005109147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001208521,"about_ca_topic_score_gemma":0.002577665,"domain_scores_codex":[0.9999163,0.00001038273,0.00001156245,0.00001724118,0.00003463192,0.000009826032],"domain_scores_gemma":[0.9999197,0.00002369854,0.00001781882,0.000002564108,0.00002250869,0.00001383065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009828827,0.00008968917,0.0001734406,0.01044514,0.00007783017,0.0004024985,0.0000480088,0.0001985444,0.003042997,0.000682248,0.01708186,0.9676595],"study_design_scores_gemma":[0.00005710775,0.0001483404,0.001602915,0.00130093,0.0001540971,0.003543263,0.00005859118,0.00008621286,0.001093722,0.0005411098,0.991398,0.00001568493],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003543834,0.9980212,0.000142438,0.0001285654,0.00008583711,0.000007563877,0.00002391295,0.00001598792,0.001219986],"genre_scores_gemma":[0.001691089,0.9964959,0.0002292875,0.0001290728,0.00008185592,0.000007811203,0.00006311169,0.000001802919,0.001299987],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004195324,"threshold_uncertainty_score":0.01403481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253026915","doi":"10.1358/dot.2003.39.4.799404","title":"Aminoglycoside ototoxicity","year":2003,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Aminoglycoside; Ototoxicity; Medicine; Pharmacology; Toxicity; Antibiotics; Gentamicin; Hearing loss; Internal medicine; Genetics; Biology; Audiology; Chemotherapy","authors":[{"name":"Duane Bates","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09214801784366826,"gpt":0.3536444778535877,"spread":0.2614964600099194,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003436158,0.001502184,0.00198067,0.002623294,0.000427056,0.0009377571,0.0007730198,0.001308492,0.004105336],"category_scores_gemma":[0.00063522,0.0002012844,0.0004586186,0.00198404,0.0005682086,0.001088368,0.0006861296,0.001183404,0.003406813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006378012,"about_ca_system_score_gemma":0.0008132771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001159762,"about_ca_topic_score_gemma":0.002137878,"domain_scores_codex":[0.9997235,0.00003420749,0.00005148186,0.00005069913,0.0001135355,0.00002649933],"domain_scores_gemma":[0.9996283,0.0001341753,0.00007244974,0.0000153146,0.0001123374,0.00003732934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005412797,0.0000591481,0.0004493929,0.009075974,0.00006007812,0.001172654,0.00004668196,0.0001905562,0.001609556,0.0008248485,0.02275192,0.963705],"study_design_scores_gemma":[0.00002706883,0.0001324267,0.002839432,0.003731683,0.0001532442,0.02408301,0.000137521,0.000129825,0.001591426,0.002161883,0.9649863,0.00002631637],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002151435,0.9975701,0.0001401139,0.0001761539,0.0001807572,0.000004111962,0.00001342976,0.00001460946,0.001685503],"genre_scores_gemma":[0.001505758,0.996987,0.0001409677,0.0001784317,0.0002199384,0.000004437068,0.00002766814,0.000001909058,0.0009339775],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004105336,"threshold_uncertainty_score":0.01373369,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2317463698","doi":"10.1358/dot.2000.36.2-3.568786","title":"Sildenafil citrate (Viagra(R))","year":2000,"lang":"en","type":"article","venue":"Drugs of today","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Sildenafil; Medicine; Cyclic guanosine monophosphate; Erectile dysfunction; cGMP-specific phosphodiesterase type 5; Pharmacology; Erectile function; Phosphodiesterase; Phosphodiesterase inhibitor; Internal medicine; Urology; Biochemistry; Enzyme","authors":[{"name":"Gerald Brock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01380552254417854,"gpt":0.2656979121947541,"spread":0.2518923896505755,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001262591,0.000429032,0.0005067241,0.0005510692,0.0002515146,0.000414124,0.0003345943,0.0007242702,0.01807632],"category_scores_gemma":[0.0003077158,0.0001099028,0.0002587047,0.0003696129,0.0002364539,0.0002602348,0.0003333252,0.0006620911,0.008090259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001811771,"about_ca_system_score_gemma":0.0003805816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004407169,"about_ca_topic_score_gemma":0.0006507387,"domain_scores_codex":[0.9998325,0.00002439541,0.00001279912,0.00005504438,0.00005031237,0.00002499957],"domain_scores_gemma":[0.9999176,0.000009885597,0.00001885596,0.00001045225,0.00001002941,0.00003315809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00671195,0.002047882,0.003009693,0.001667483,0.0001652714,0.001679825,0.0001507558,0.0003091321,0.3697748,0.003265045,0.02539825,0.5858199],"study_design_scores_gemma":[0.004471288,0.03559154,0.02659061,0.000297178,0.0006260889,0.01819501,0.00009147578,0.001373263,0.2402311,0.0008423789,0.6716176,0.00007241556],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6642454,0.1569181,0.01552845,0.003564351,0.003394052,0.002426329,0.009961923,0.005405918,0.1385554],"genre_scores_gemma":[0.863198,0.04476936,0.01158325,0.002323159,0.001775982,0.000565414,0.006161536,0.0001745491,0.06944864],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01807632,"threshold_uncertainty_score":0.06047136,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200087363","doi":"10.1358/dot.2021.57.12.3352740","title":"Casimersen for Duchenne muscular dystrophy","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Medicine; Exon skipping; Duchenne muscular dystrophy; Dystrophin; Exon; Muscular dystrophy; Population; Antisense therapy; Bioinformatics; Clinical trial; Pharmacology; Internal medicine; Genetics; Gene; Oligonucleotide; Biology; Alternative splicing","authors":[{"name":"Harry Wilton-Clark","is_ca":true},{"name":"Tsukasa Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005900815163805081,"gpt":0.2427122663161498,"spread":0.2368114511523448,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007494143,0.0010492,0.0006615291,0.001114029,0.000638939,0.0007730316,0.0005718856,0.001926715,0.04131789],"category_scores_gemma":[0.000883963,0.0001877374,0.000527715,0.0005398389,0.0005679915,0.0006592133,0.0009643275,0.002282169,0.02655514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007460916,"about_ca_system_score_gemma":0.000915189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003958864,"about_ca_topic_score_gemma":0.00101462,"domain_scores_codex":[0.9995932,0.00007984223,0.00003295192,0.00009921471,0.0001348515,0.00005983917],"domain_scores_gemma":[0.9995597,0.00008462917,0.0001043398,0.00003269888,0.00007144183,0.0001471008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001242539,0.0002687982,0.0002931714,0.002415632,0.00008012733,0.001806048,0.0001171718,0.0003085189,0.04315785,0.02298638,0.3063356,0.6209881],"study_design_scores_gemma":[0.0002618702,0.0004354881,0.0004236878,0.0002298569,0.00001814535,0.002427661,0.00001031613,0.00008629208,0.005859119,0.001826453,0.9884007,0.00002034287],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01849175,0.6208825,0.01237484,0.02954658,0.0232755,0.000905108,0.001993346,0.003638269,0.2888922],"genre_scores_gemma":[0.1317619,0.2856575,0.02071556,0.02584687,0.01005457,0.002097409,0.004330075,0.0006085333,0.5189276],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04131789,"threshold_uncertainty_score":0.1382221,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2942062551","doi":"10.1358/dot.2019.55.4.2958476","title":"Encorafenib and binimetinib for the treatment of BRAFV600E/K-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Melanoma; MAPK/ERK pathway; Metastatic melanoma; V600E; Cancer research; Oncology; Kinase; Pharmacology; Mutation; Internal medicine; Biology; Genetics","authors":[{"name":"April A. N. Rose","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04074034639323368,"gpt":0.3182639523817377,"spread":0.277523605988504,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002481639,0.000605996,0.0007171097,0.001883924,0.0001956706,0.0005221352,0.0005480084,0.000652875,0.004716574],"category_scores_gemma":[0.000325389,0.00016606,0.0004178761,0.001207018,0.0001947569,0.0007188828,0.0003955143,0.001456033,0.002341144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003901703,"about_ca_system_score_gemma":0.0005359141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007050188,"about_ca_topic_score_gemma":0.002323602,"domain_scores_codex":[0.9999064,0.0000123026,0.00001224221,0.00001674428,0.00004126289,0.00001097943],"domain_scores_gemma":[0.9999177,0.0000286588,0.00001514114,0.000002434205,0.00002413265,0.00001199193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008522425,0.00007563192,0.0001156863,0.00818128,0.00007345725,0.0001915146,0.00003549716,0.0002773221,0.002285357,0.001960012,0.03376233,0.9529568],"study_design_scores_gemma":[0.00002489481,0.00009980304,0.0005299507,0.001278883,0.00006886985,0.001328944,0.00001811938,0.00006627305,0.0005066556,0.0006992474,0.9953682,0.00001016367],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002849543,0.9966056,0.000142998,0.0002573525,0.0002481832,0.000009359041,0.0000448315,0.00001316623,0.00239352],"genre_scores_gemma":[0.001192986,0.996086,0.0002001515,0.0002996029,0.0001319904,0.0000110616,0.00008576901,0.000002247735,0.001990222],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004716574,"threshold_uncertainty_score":0.01577854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2041935038","doi":"10.1358/dot.2008.44.7.1227147","title":"Desvenlafaxine succinate for major depressive disorder","year":2008,"lang":"en","type":"review","venue":"Drugs of today","topic":"Treatment of Major Depression","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Venlafaxine; Internal medicine; Adverse effect; Pharmacology; Antidepressant; Vasomotor; Endocrinology","authors":[{"name":"Beth Sproule","is_ca":true},{"name":"Monica Hazra","is_ca":false},{"name":"Bruce G. Pollock","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02766957565775824,"gpt":0.3371435443253235,"spread":0.3094739686675653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003446657,0.000289781,0.0004943016,0.0002024352,0.0002675277,0.0002973639,0.0002816412,0.0006005418,0.01110687],"category_scores_gemma":[0.000781502,0.00006896303,0.0006054475,0.000186351,0.0001284899,0.0002181863,0.0002368208,0.0009045299,0.003221259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005698983,"about_ca_system_score_gemma":0.0003431403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007574777,"about_ca_topic_score_gemma":0.003650256,"domain_scores_codex":[0.9998519,0.00004534232,0.00002730196,0.0000184579,0.00003201743,0.00002492013],"domain_scores_gemma":[0.999811,0.00004510615,0.00004617612,0.000008220795,0.00003675234,0.00005282408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008947888,0.001203413,0.006686165,0.003022222,0.0006226375,0.001888191,0.0001010385,0.0002590409,0.01737085,0.001708769,0.1124099,0.8457799],"study_design_scores_gemma":[0.02097851,0.01427017,0.1078963,0.0025412,0.000950475,0.01667093,0.0002368066,0.001225865,0.01029475,0.003724267,0.8211173,0.00009337598],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2748618,0.4990215,0.008189419,0.04182453,0.005178788,0.002291127,0.005184085,0.001312755,0.162136],"genre_scores_gemma":[0.7503863,0.1375821,0.008551138,0.02982763,0.002001158,0.001120658,0.005416092,0.00008917891,0.06502581],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01110687,"threshold_uncertainty_score":0.03715622,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253652799","doi":"10.1358/dot.2011.47.10.1656503","title":"Boceprevir","year":2011,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Boceprevir; Medicine; Ribavirin; Pharmacology; Hepatitis C virus; Telaprevir; Virology; Internal medicine; Virus","authors":[{"name":"S.A. Rizza","is_ca":false},{"name":"R. Talwani","is_ca":false},{"name":"V Nehra","is_ca":false},{"name":"Z. Temesgen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1213898191552022,"gpt":0.4169331912826664,"spread":0.2955433721274641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002741395,0.0008290266,0.0009049812,0.001291814,0.0002229416,0.0005462739,0.0007434337,0.0007635037,0.009116028],"category_scores_gemma":[0.0003130587,0.0001864845,0.0005300124,0.0008943395,0.0001856154,0.0005300855,0.0003604057,0.001493817,0.007614905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004683551,"about_ca_system_score_gemma":0.0003846549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001317147,"about_ca_topic_score_gemma":0.002302354,"domain_scores_codex":[0.9998516,0.00002813398,0.00001699082,0.00003148534,0.00005075091,0.00002098935],"domain_scores_gemma":[0.9999319,0.00001986868,0.00001633066,0.000003106215,0.00001664158,0.00001211041],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003030632,0.00009084537,0.0001052135,0.006490396,0.00009957271,0.0002922496,0.00002836417,0.0001675611,0.002927882,0.001660219,0.04552593,0.9423087],"study_design_scores_gemma":[0.0001735155,0.0001679302,0.0008140378,0.00115862,0.00009639659,0.002307079,0.00001550596,0.00007130686,0.001389865,0.0005925578,0.9931961,0.00001709833],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007755538,0.9893421,0.0004781903,0.0004354732,0.0004450982,0.00004074148,0.0002137698,0.00008283369,0.008186249],"genre_scores_gemma":[0.009497752,0.9774185,0.001310582,0.001191731,0.0003006225,0.00005618185,0.0007345281,0.00001357155,0.009476671],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009116028,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2064695702","doi":"10.1358/dot.2002.38.1.677133","title":"Medical backgrounder on varicocele","year":2002,"lang":"en","type":"review","venue":"Drugs of today","topic":"Sperm and Testicular Function","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Varicocele; Medicine; Hydrocele; Male infertility; Semen quality; Infertility; Urology; Semen; Surgery; Andrology; Pregnancy; Biology","authors":[{"name":"Peter Chan","is_ca":true},{"name":"Marc Goldstein","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05104752085932522,"gpt":0.329940138467689,"spread":0.2788926176083638,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002716426,0.0009909978,0.00110106,0.002533908,0.0004471264,0.0008106611,0.0008542601,0.001146822,0.03479533],"category_scores_gemma":[0.001112517,0.0001952511,0.0003838772,0.003355569,0.0004019333,0.001376243,0.0006505366,0.001140354,0.02272115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004836063,"about_ca_system_score_gemma":0.001139644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00141481,"about_ca_topic_score_gemma":0.002010785,"domain_scores_codex":[0.9997739,0.00003753015,0.00003147554,0.00004310328,0.00008784996,0.00002618553],"domain_scores_gemma":[0.9996266,0.0001233534,0.00006686477,0.00001908064,0.0001129349,0.00005114686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008053511,0.00006816172,0.0003413681,0.008108404,0.00003682109,0.0007818578,0.0000649775,0.0001410126,0.0008513341,0.001543709,0.1880751,0.7999066],"study_design_scores_gemma":[0.0000109368,0.00003225688,0.0008864564,0.002067796,0.00002636228,0.002215745,0.00002547671,0.00002208578,0.0001333466,0.0003990233,0.9941737,0.000006782316],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002811825,0.9764331,0.000160892,0.001204136,0.003578006,0.00001863388,0.00008409627,0.00003115449,0.01820881],"genre_scores_gemma":[0.002343571,0.9728852,0.00028555,0.001805024,0.003418452,0.00001867424,0.0002041828,0.000008329414,0.01903106],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03479533,"threshold_uncertainty_score":0.116402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W183877133","doi":"10.1358/dot.2012.48.12.1885866","title":"Remestemcel-L, the first cellular therapy product for the treatmentof graft-versus-host disease","year":2012,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Mesenchymal stem cell; Graft-versus-host disease; Disease; Transplantation; Cell therapy; Front line; Stem cell; Immunology; Surgery; Internal medicine; Pathology","authors":[{"name":"Andrew Daly","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07970850809014411,"gpt":0.3356937943612554,"spread":0.2559852862711113,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002197882,0.0006788287,0.0008556638,0.001710612,0.0001992572,0.0005037189,0.0005820315,0.0005714259,0.003385998],"category_scores_gemma":[0.0002521447,0.0001452908,0.0003401841,0.001233024,0.0002756281,0.0007364514,0.000400445,0.0009645118,0.002211845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003365756,"about_ca_system_score_gemma":0.0004981062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005636635,"about_ca_topic_score_gemma":0.00123107,"domain_scores_codex":[0.9998816,0.00001711103,0.00001585168,0.00002105899,0.00005308887,0.0000113489],"domain_scores_gemma":[0.9999001,0.00003709526,0.00002369789,0.000003865216,0.00002263033,0.00001251872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000877758,0.00008690928,0.0001605819,0.007271605,0.00005076674,0.0002443431,0.00003325667,0.0001497523,0.005094476,0.000906212,0.008035898,0.9778783],"study_design_scores_gemma":[0.00003503638,0.0002243893,0.001250836,0.001380856,0.0001094797,0.003646007,0.00003698047,0.0000666881,0.004015545,0.0004749126,0.9887394,0.00001992767],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006618323,0.9970577,0.0001906375,0.0001327613,0.0001017845,0.000009317065,0.00003488331,0.00001537275,0.00179587],"genre_scores_gemma":[0.003543928,0.9939398,0.0004012098,0.0001922388,0.00008157278,0.00001302082,0.00008838022,0.000003222183,0.001736671],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003385998,"threshold_uncertainty_score":0.01132727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995684830","doi":"10.1358/dot.2006.42.3.957358","title":"Clinical experience with erlotinib in non-small-cell lung cancer(NSCLC)","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Lung cancer; Epidermal growth factor receptor; Erlotinib Hydrochloride; Oncology; Tyrosine kinase; EGFR inhibitors; Cancer research; Cancer; T790M; Tyrosine-kinase inhibitor; Clinical trial; Internal medicine; Pharmacology; Gefitinib; Receptor","authors":[{"name":"Enriqueta Felip","is_ca":false},{"name":"Rafael Rosell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03141548310013683,"gpt":0.4158838494868783,"spread":0.3844683663867415,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009378126,0.0004379216,0.0006613116,0.0002588308,0.0003695902,0.000536709,0.0003216888,0.0005226037,0.002004848],"category_scores_gemma":[0.001315511,0.0000863233,0.0005432459,0.0005766906,0.0001777523,0.0005396249,0.0003604813,0.001306538,0.00123933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003861242,"about_ca_system_score_gemma":0.0003643553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004586868,"about_ca_topic_score_gemma":0.0009987525,"domain_scores_codex":[0.9996983,0.0001004302,0.00004175764,0.00005006068,0.00006923894,0.0000402696],"domain_scores_gemma":[0.9996642,0.0001071583,0.00004904624,0.00002145915,0.00005552296,0.000102609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003489265,0.001386811,0.0119694,0.001749311,0.0004359554,0.00268783,0.0004755029,0.0004776198,0.008764334,0.0006420664,0.02031329,0.9476086],"study_design_scores_gemma":[0.00503716,0.03713548,0.1349536,0.00243761,0.001916373,0.05400372,0.0005445863,0.001563983,0.01893763,0.001317016,0.7420037,0.0001491462],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2974916,0.6627792,0.002524053,0.007054506,0.001547559,0.0002606453,0.0008576413,0.0001354293,0.02734931],"genre_scores_gemma":[0.6515679,0.3217292,0.002287752,0.006936184,0.001727115,0.000186133,0.002551914,0.00006859504,0.01294532],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002004848,"threshold_uncertainty_score":0.006706953,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2038264909","doi":"10.1358/dot.2003.39.8.799407","title":"Role of 5-HT receptors in treatment of overactive bladder","year":2003,"lang":"en","type":"review","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Serotonergic; Overactive bladder; Urination; Reflex; Duloxetine; Urology; Urinary bladder; Urethral sphincter; Receptor; Internal medicine; Endocrinology; Pharmacology; Serotonin; Urethra; Urinary system; Pathology","authors":[{"name":"Sabri Mahmoud Khaled","is_ca":true},{"name":"Mostafa Elhilali","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04058001073595981,"gpt":0.3736951977028197,"spread":0.3331151869668599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003993132,0.0006659228,0.001248562,0.002105539,0.0002449371,0.0005133895,0.0008903578,0.0008825508,0.004642875],"category_scores_gemma":[0.0003566174,0.000181935,0.0004031611,0.001873121,0.0003157751,0.000655334,0.0003457405,0.001070287,0.002064984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004434467,"about_ca_system_score_gemma":0.0006073152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00156501,"about_ca_topic_score_gemma":0.003582889,"domain_scores_codex":[0.9998803,0.00002605231,0.00001615364,0.00001872566,0.00004672354,0.00001200301],"domain_scores_gemma":[0.9998637,0.00006672066,0.00002353508,0.000004476289,0.00002802445,0.00001360694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000104198,0.0001070079,0.0001673331,0.01173395,0.00008827892,0.0004118423,0.00005760053,0.0003204172,0.00153087,0.00126466,0.01467788,0.969536],"study_design_scores_gemma":[0.00007338946,0.0002520381,0.00260252,0.004950942,0.0002062345,0.00322169,0.0001126802,0.0001573434,0.0008592217,0.001616997,0.985927,0.00001991187],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001568301,0.9987092,0.00006158779,0.0001042374,0.00008198164,0.000005040702,0.00001099275,0.00000607338,0.0008640111],"genre_scores_gemma":[0.0009121933,0.9981902,0.0001447213,0.00009625305,0.00006720661,0.000007137685,0.00002011779,9.623947e-7,0.0005612341],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004642875,"threshold_uncertainty_score":0.01553196,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2376717750","doi":"10.1358/dot.2013.49.12.2067249","title":"Simeprevir for the treatment of genotype 1 chronic hepatitis Cvirus","year":2013,"lang":"en","type":"article","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Simeprevir; Ribavirin; Medicine; Pegylated interferon; Virology; Hepatitis C virus; Genotype; Protease inhibitor (pharmacology); Interferon; Internal medicine; Pharmacology; Virus; Viral load; Biology","authors":[{"name":"Rohit Talwani","is_ca":false},{"name":"Emily L. Heil","is_ca":false},{"name":"Bruce L. Gilliam","is_ca":false},{"name":"Zelalem Temesgen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02708515269192192,"gpt":0.3213115087311132,"spread":0.2942263560391913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002866726,0.000264412,0.0002852363,0.0003237753,0.0001956398,0.0001356084,0.0001595081,0.000312398,0.005517607],"category_scores_gemma":[0.0002844835,0.00004132152,0.0002490506,0.0002231686,0.0001135945,0.0001820709,0.0001528902,0.0006994714,0.00163329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001904782,"about_ca_system_score_gemma":0.0002914645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002093078,"about_ca_topic_score_gemma":0.0005272065,"domain_scores_codex":[0.9999222,0.00002493022,0.000007136527,0.000009626931,0.00002189836,0.00001420583],"domain_scores_gemma":[0.9999323,0.00001599036,0.00001322879,0.000004451283,0.00001186321,0.00002216935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002001249,0.0004076871,0.002858552,0.0009081742,0.00008144878,0.001597054,0.00009699652,0.0002124418,0.02421515,0.00270282,0.04145508,0.9234632],"study_design_scores_gemma":[0.003423142,0.006652952,0.02305688,0.0005983144,0.0001494301,0.01858254,0.00008425781,0.001081699,0.01995219,0.003569044,0.9228099,0.00003952147],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1962619,0.659196,0.008873669,0.018851,0.002905427,0.0006778206,0.001449094,0.001244885,0.1105403],"genre_scores_gemma":[0.7898209,0.1445808,0.009523297,0.009074242,0.002677024,0.0003135623,0.00239537,0.00008879948,0.04152606],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005517607,"threshold_uncertainty_score":0.01845825,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079795343","doi":"10.1358/dot.2011.47.5.1584113","title":"Psychosis in Parkinson's disease: Therapeutic options","year":2011,"lang":"en","type":"review","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Quetiapine; Ziprasidone; Medicine; Psychosis; Clozapine; Olanzapine; Risperidone; Rivastigmine; Parkinson's disease; Psychiatry; Donepezil; Antipsychotic; Amantadine; Amisulpride; Disease; Schizophrenia (object-oriented programming); Intensive care medicine; Dementia; Pharmacology; Internal medicine","authors":[{"name":"Mehrul Hasnain","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05147819620287031,"gpt":0.3382877219087331,"spread":0.2868095257058628,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004899923,0.0009650321,0.001769951,0.002778374,0.000267692,0.0008786793,0.0005609326,0.0008566611,0.005245622],"category_scores_gemma":[0.0006395062,0.000255192,0.0006110295,0.002672972,0.0004419071,0.001209818,0.0005646642,0.001340211,0.001400093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005926164,"about_ca_system_score_gemma":0.001035233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001264176,"about_ca_topic_score_gemma":0.003474461,"domain_scores_codex":[0.9997528,0.0000559966,0.00004760998,0.00002995276,0.00009625563,0.00001740328],"domain_scores_gemma":[0.9997156,0.0001507068,0.00005756112,0.000009710197,0.00004417162,0.00002219585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008333369,0.00007220422,0.0001246815,0.04174679,0.0001429025,0.0003621104,0.0000920254,0.000284693,0.0008398688,0.002877941,0.02319472,0.9301788],"study_design_scores_gemma":[0.0000685776,0.000130901,0.001565254,0.01999162,0.000291735,0.003913745,0.0001640243,0.00009544858,0.000239118,0.003771925,0.9697436,0.00002405632],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000432929,0.9991934,0.00002792368,0.0001342139,0.00006129267,0.000002271371,0.000004304964,0.000002436184,0.0005309051],"genre_scores_gemma":[0.0004986451,0.9989299,0.00008230963,0.0001280083,0.0000950406,0.000003302416,0.000008334689,5.684563e-7,0.0002537383],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005245622,"threshold_uncertainty_score":0.01754838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988535187","doi":"10.1358/dot.2009.45.10.1417873","title":"Degarelix for the treatment of prostate cancer","year":2009,"lang":"en","type":"review","venue":"Drugs of today","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Testosterone (patch); Castration; Androgen deprivation therapy; Gonadotropin-releasing hormone; Hormone antagonist; Prostate; Management of prostate cancer; Orchiectomy; Hormone; Internal medicine; Urology; Oncology; Cancer; Endocrine system; Luteinizing hormone","authors":[{"name":"Laurence Klotz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06837846130566895,"gpt":0.4177318112487104,"spread":0.3493533499430415,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002745018,0.000856433,0.0009484483,0.002563507,0.0002887564,0.0005485294,0.000605981,0.0005817816,0.009069661],"category_scores_gemma":[0.0002888126,0.0001821457,0.000482329,0.002165939,0.00029275,0.0008044484,0.0004782977,0.001601824,0.004884439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003197369,"about_ca_system_score_gemma":0.0004671708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001013138,"about_ca_topic_score_gemma":0.002013586,"domain_scores_codex":[0.9998698,0.00001842453,0.00001433206,0.00002765064,0.00005633371,0.00001345557],"domain_scores_gemma":[0.999893,0.0000407175,0.00002845702,0.000003793712,0.00001884444,0.00001521818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001018362,0.0000951246,0.000154464,0.009010065,0.0000889205,0.0002812112,0.00004408989,0.0001924045,0.002413336,0.001506617,0.03168621,0.9544257],"study_design_scores_gemma":[0.00005222217,0.0001203425,0.0009865707,0.001871915,0.0001086995,0.002901322,0.00003220043,0.0000540641,0.0006225328,0.00108005,0.9921556,0.00001461318],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001931116,0.9971506,0.0001151511,0.0001315767,0.0001432794,0.000009407428,0.0000263708,0.00001399301,0.002216533],"genre_scores_gemma":[0.001552905,0.9953407,0.0002681043,0.000272739,0.0001992794,0.000009381205,0.00008634466,0.000003266196,0.002267342],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009069661,"threshold_uncertainty_score":0.03034103,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2325941892","doi":"10.1358/dot.2000.36.2-3.568785","title":"Oral phentolamine (Vasomax(R))","year":2000,"lang":"en","type":"article","venue":"Drugs of today","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Phentolamine; Medicine; Sympatholytic; Anesthesia; Internal medicine; Blood pressure; Propranolol","authors":[{"name":"Gerald Brock","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01142971626322359,"gpt":0.26645212058433,"spread":0.2550224043211064,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001066465,0.0002047967,0.0002649202,0.0004110174,0.0001289844,0.0001763006,0.000167127,0.0003002789,0.005308679],"category_scores_gemma":[0.0001402573,0.0000489058,0.0001138584,0.0002193908,0.0001049025,0.0001465179,0.0001696542,0.0002808197,0.001979106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008292781,"about_ca_system_score_gemma":0.0001065935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002416566,"about_ca_topic_score_gemma":0.0004422434,"domain_scores_codex":[0.9999609,0.000007781869,0.000003423838,0.000007845328,0.00001307083,0.000006884466],"domain_scores_gemma":[0.9999607,0.00001309774,0.00001091738,0.000002022971,0.000003655614,0.000009599131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006488792,0.0002298638,0.0008625857,0.001553062,0.00002643318,0.001121121,0.00005993999,0.00004550844,0.07428408,0.0008566276,0.006043036,0.9142688],"study_design_scores_gemma":[0.0006394525,0.01161326,0.02468115,0.0007274937,0.0002176722,0.02403988,0.0001694211,0.0002491124,0.07899443,0.000798277,0.8578389,0.00003099381],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.160951,0.7759879,0.006060084,0.001510997,0.001052875,0.000195507,0.0006659392,0.0004795396,0.05309612],"genre_scores_gemma":[0.42599,0.5027097,0.008861817,0.002619957,0.001187596,0.0001748127,0.001353802,0.00006132442,0.05704099],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005308679,"threshold_uncertainty_score":0.01775932,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4212843950","doi":"10.1358/dot.2022.58.2.3367993","title":"Loteprednol etabonate: a formulation for short-term use in inflammatory flares in dry eye disease","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Corticosteroid; Pharmacokinetics; Ophthalmology; Pharmacology; Internal medicine","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01464491434465334,"gpt":0.2691281263938503,"spread":0.2544832120491969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002462141,0.0002289424,0.0002531448,0.0004280307,0.000246578,0.0003240318,0.0003082655,0.000685458,0.002264064],"category_scores_gemma":[0.0002403592,0.0001053783,0.0003248208,0.0001914742,0.0001972006,0.0004537693,0.0002674578,0.0007948478,0.0008201153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003040348,"about_ca_system_score_gemma":0.0002297099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005686309,"about_ca_topic_score_gemma":0.001213471,"domain_scores_codex":[0.9998893,0.00002033348,0.0000120064,0.00001786555,0.00004510405,0.00001538964],"domain_scores_gemma":[0.9999084,0.00001450183,0.0000269848,0.000004987707,0.00001439253,0.00003064796],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003761192,0.0009185273,0.0005978998,0.00145296,0.00005457614,0.001083576,0.0001351308,0.0001941126,0.6988822,0.000714036,0.004572154,0.2876337],"study_design_scores_gemma":[0.00684339,0.03089359,0.0289849,0.0004179552,0.0003027474,0.02034412,0.0001895237,0.003710156,0.59374,0.0005758262,0.3138612,0.0001366539],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.7863883,0.1776844,0.01604009,0.002791241,0.001281068,0.001143016,0.00119809,0.0009229779,0.01255087],"genre_scores_gemma":[0.9436015,0.02827842,0.01410504,0.0009285678,0.0003093058,0.0004067298,0.0009904752,0.00008869523,0.01129129],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.002264064,"threshold_uncertainty_score":0.007574022,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020779524","doi":"10.1358/dot.2004.40.10.863742","title":"Gefitinib: Current status in the treatment of non-small cell lungcancer","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Gefitinib; Medicine; Lung cancer; Tolerability; Oncology; Epidermal growth factor receptor; Internal medicine; Chemotherapy; Tyrosine-kinase inhibitor; Cancer; Adverse effect","authors":[{"name":"Adnan Tanovı́c","is_ca":false},{"name":"Vicente Alfaro","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03334470967723603,"gpt":0.3830884928690895,"spread":0.3497437831918535,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002615502,0.0009465958,0.001718549,0.001196231,0.0005173967,0.002382718,0.001114216,0.002321562,0.007337233],"category_scores_gemma":[0.002215478,0.0002681063,0.0005708702,0.00212421,0.001047089,0.003406018,0.0009776973,0.002522455,0.004721118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001258436,"about_ca_system_score_gemma":0.002600447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001067917,"about_ca_topic_score_gemma":0.002111793,"domain_scores_codex":[0.9993958,0.0001119268,0.000101434,0.0001114466,0.0001677409,0.000111583],"domain_scores_gemma":[0.9980166,0.0004579331,0.0003206745,0.000050429,0.0005525024,0.0006018815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005023279,0.0001328287,0.0005699021,0.003182165,0.0000432026,0.0001041409,0.00004994598,0.0002253496,0.001136122,0.001799831,0.04727717,0.9449771],"study_design_scores_gemma":[0.0001488033,0.0008169988,0.001962783,0.001441526,0.0001264208,0.0007358416,0.00005277041,0.000467894,0.0006719731,0.001225194,0.9923183,0.00003167226],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009040925,0.9906872,0.0003839835,0.004024921,0.001103022,0.00001996198,0.00008128887,0.00008409118,0.002711417],"genre_scores_gemma":[0.01223279,0.9763321,0.00109141,0.002857677,0.003302921,0.00006994385,0.0004947014,0.00003038476,0.003588143],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007337233,"threshold_uncertainty_score":0.02454555,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006524053","doi":"10.1358/dot.2020.56.1.3069863","title":"Galcanezumab: a humanized monoclonal antibody for the prevention ofmigraine and cluster headache","year":2020,"lang":"en","type":"article","venue":"Drugs of today","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Migraine; Medicine; Triptans; Calcitonin gene-related peptide; Cluster headache; Chronic Migraine; Headaches; Clinical trial; Rizatriptan; Pharmacology; Bioinformatics; Internal medicine; Sumatriptan; Receptor; Psychiatry; Neuropeptide","authors":[{"name":"Michael H. Ossipov","is_ca":false},{"name":"Robert B. Raffa","is_ca":false},{"name":"Joseph V. Pergolizzi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03827635726970599,"gpt":0.3370591633159204,"spread":0.2987828060462144,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000208375,0.0003288892,0.0003018081,0.0003744076,0.0002526377,0.0002954176,0.0003358211,0.0006210876,0.003359376],"category_scores_gemma":[0.0001716511,0.00008418368,0.0002724355,0.0002235348,0.0002071411,0.0002497454,0.0001824918,0.0007895413,0.0007649281],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004994884,"about_ca_system_score_gemma":0.0004870781,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00122164,"about_ca_topic_score_gemma":0.002726917,"domain_scores_codex":[0.999921,0.0000143123,0.000003508705,0.00001119103,0.00002233731,0.00002780623],"domain_scores_gemma":[0.9999578,0.000004588094,0.000006653773,0.000002625711,0.000008214354,0.00002007706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01215284,0.00492558,0.003224883,0.001240752,0.0002859979,0.001308567,0.0001350781,0.0003776191,0.1606558,0.001579461,0.03091464,0.7831988],"study_design_scores_gemma":[0.04319932,0.07151654,0.09070293,0.0004771761,0.001004735,0.01868699,0.0001581036,0.002789312,0.16622,0.001340057,0.6037514,0.0001534435],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.8272839,0.1197374,0.002877761,0.005273113,0.001970323,0.001206617,0.001261359,0.001223803,0.03916575],"genre_scores_gemma":[0.952611,0.0246092,0.002847568,0.002736921,0.0004537682,0.0002930202,0.001375644,0.00003197683,0.01504091],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.003359376,"threshold_uncertainty_score":0.01123822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4322495836","doi":"10.1358/dot.2023.59.3.3521858","title":"Cenegermin for the treatment of dry eye disease","year":2023,"lang":"en","type":"review","venue":"Drugs of today","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Tropomyosin receptor kinase A; Nerve growth factor; Clinical trial; Disease; Authorization; Intensive care medicine; Ophthalmology; Internal medicine; Receptor","authors":[{"name":"Giulia Coco","is_ca":false},{"name":"Giulia Piccotti","is_ca":false},{"name":"Vito Romano","is_ca":true},{"name":"Lorenzo Ferro Desideri","is_ca":false},{"name":"Aldo Vagge","is_ca":false},{"name":"Carlo Enrico Traverso","is_ca":false},{"name":"Marco Pellegrini","is_ca":false},{"name":"Alice Bruscolini","is_ca":false},{"name":"Marco Marenco","is_ca":false},{"name":"Giuseppe Giannaccare","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05328641506398813,"gpt":0.3666833527670074,"spread":0.3133969377030193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003249993,0.0006153818,0.0009638756,0.002163946,0.0002247939,0.0007008056,0.0005967313,0.0007441548,0.006607501],"category_scores_gemma":[0.0004288807,0.0001589092,0.0006526094,0.001113803,0.0002448761,0.0005598635,0.0004437953,0.001550626,0.002429582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003352919,"about_ca_system_score_gemma":0.0005081565,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00093885,"about_ca_topic_score_gemma":0.002148744,"domain_scores_codex":[0.9998515,0.00002811246,0.00002418717,0.00002507067,0.00005609492,0.00001504515],"domain_scores_gemma":[0.999892,0.00005073844,0.00001966783,0.000003531097,0.00002335962,0.00001067612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001340142,0.00009716924,0.0001055269,0.02048471,0.0001535724,0.0002163608,0.00005021804,0.0001944663,0.002489182,0.001860791,0.01981132,0.9544027],"study_design_scores_gemma":[0.00007641288,0.0001615245,0.0009766489,0.004621694,0.0002182667,0.001663272,0.00004328235,0.0000769426,0.0008657661,0.0009089225,0.990371,0.00001626344],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002656425,0.9977666,0.0001036178,0.0001432072,0.0001764162,0.00001071392,0.00003572592,0.00001098535,0.0014871],"genre_scores_gemma":[0.002144838,0.9957825,0.0002543879,0.0002529714,0.00009961746,0.00001358567,0.00007791499,0.000003086598,0.001371188],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006607501,"threshold_uncertainty_score":0.02210432,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200565889","doi":"10.1358/dot.2021.57.12.3352760","title":"Delgocitinib in atopic dermatitis","year":2021,"lang":"en","type":"review","venue":"Drugs of today","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Tacrolimus; Calcineurin; Pimecrolimus; Janus kinase; Clinical trial; Dermatology; Safety profile; Ciclosporin; Pharmacology; Quality of life (healthcare); Pharmacokinetics; Janus kinase inhibitor; Adverse effect; Immunology; Transplantation; Internal medicine; Cytokine","authors":[{"name":"Johne Ho","is_ca":true},{"name":"Sonja Molin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02845163800676103,"gpt":0.3400481662397611,"spread":0.311596528233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002325172,0.0004361402,0.0008047509,0.001501174,0.0001960132,0.0006397789,0.000382811,0.0005486604,0.00564421],"category_scores_gemma":[0.0002899446,0.0001375383,0.000493197,0.0009913298,0.0001240102,0.000480251,0.0003689233,0.0009439618,0.001606638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003086634,"about_ca_system_score_gemma":0.0004771347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007025743,"about_ca_topic_score_gemma":0.001991917,"domain_scores_codex":[0.9999083,0.00001481417,0.00001544154,0.00001671164,0.00003289621,0.0000117676],"domain_scores_gemma":[0.9999214,0.00003678375,0.00001605762,0.000001967894,0.00001579889,0.000007834647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001126667,0.00006944069,0.0001342885,0.02008023,0.0001130748,0.0002016213,0.0000333372,0.0002347061,0.001616543,0.001314602,0.01827096,0.9578185],"study_design_scores_gemma":[0.00007262922,0.0001639069,0.001259598,0.005644875,0.0003131181,0.002258009,0.00004160568,0.000136891,0.0008857088,0.0008666382,0.9883417,0.00001524403],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003554823,0.997785,0.00005447897,0.0001155212,0.0000984959,0.000006775114,0.00003078646,0.000007984763,0.001545548],"genre_scores_gemma":[0.002612322,0.9958543,0.0001257898,0.0001718802,0.00008334879,0.000007531678,0.00006973092,0.000001344994,0.00107388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00564421,"threshold_uncertainty_score":0.01888174,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053823757","doi":"10.1358/dot.2002.38.10.740195","title":"Identification of parkinsonism and Parkinson's disease","year":2002,"lang":"en","type":"review","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Glenrose Rehabilitation Hospital","funders":"","keywords":"Parkinsonism; Medicine; Progressive supranuclear palsy; Parkinson's disease; Disease; Magnetic resonance imaging; Neuroimaging; Dopaminergic; Movement disorders; Physical medicine and rehabilitation; Psychiatry; Pathology; Radiology; Internal medicine; Dopamine","authors":[{"name":"Richard Camicioli","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02792266007442862,"gpt":0.3044069923022708,"spread":0.2764843322278422,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001241165,0.0006152815,0.0009461945,0.003098069,0.0006933599,0.0008577781,0.0005849024,0.0009804248,0.00319644],"category_scores_gemma":[0.003271618,0.0001888169,0.0003343991,0.001691798,0.0003513733,0.0009784731,0.001231256,0.001010247,0.001352436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005851692,"about_ca_system_score_gemma":0.0008827956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003010777,"about_ca_topic_score_gemma":0.004749575,"domain_scores_codex":[0.9982589,0.0004718029,0.0002178325,0.0001921982,0.0007288015,0.0001305658],"domain_scores_gemma":[0.9988114,0.0002297527,0.000269961,0.00004452219,0.0004914113,0.000153086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007601281,0.0006506987,0.5104109,0.002026092,0.0001767836,0.007753846,0.002067049,0.0003344317,0.009673848,0.00366517,0.0311121,0.431369],"study_design_scores_gemma":[0.00009264112,0.001142811,0.7566603,0.002288221,0.0002660735,0.05157202,0.003611563,0.001512959,0.007377976,0.004812355,0.170491,0.0001720526],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6230847,0.1552269,0.02801817,0.01349575,0.002116081,0.002685613,0.005932621,0.0007343951,0.1687057],"genre_scores_gemma":[0.8724998,0.05077189,0.0420442,0.003499068,0.0007814092,0.0008054444,0.00363385,0.00005983731,0.02590457],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.00319644,"threshold_uncertainty_score":0.01069319,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294577824","doi":"10.1358/dot.2022.58.9.3422313","title":"Efficacy of vosoritide in the treatment of achondroplasia","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Achondroplasia; Medicine; Endocrinology; Natriuretic peptide; Internal medicine; Dwarfism; Mutation; NPR2; Fibroblast growth factor receptor 3; Guanosine; Mutant; Receptor; Genetics; Fibroblast growth factor; Gene; Biology; Surgery","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01305993269531803,"gpt":0.2960372429706298,"spread":0.2829773102753118,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002087576,0.0002219973,0.0004249401,0.0003245946,0.0001302632,0.0001938988,0.0002428903,0.0004157749,0.001466141],"category_scores_gemma":[0.0003228065,0.00005583826,0.0003808574,0.0001608823,0.0001210679,0.0001648272,0.0001268969,0.0006011302,0.0002507226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000173993,"about_ca_system_score_gemma":0.0002044437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008450042,"about_ca_topic_score_gemma":0.001171546,"domain_scores_codex":[0.9998935,0.0000312695,0.000009623288,0.00001450192,0.00002933167,0.00002168577],"domain_scores_gemma":[0.9998788,0.00003272043,0.00001894206,0.000006242825,0.00001791569,0.0000454321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05363142,0.008687007,0.006177542,0.002617585,0.0009221969,0.001717525,0.0001872422,0.001237604,0.2565854,0.0009970475,0.002764418,0.664475],"study_design_scores_gemma":[0.03955803,0.2770472,0.2240251,0.001588944,0.002409081,0.01138828,0.0006234829,0.005459172,0.288619,0.001231916,0.1479216,0.0001281437],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9083071,0.07710364,0.0009731677,0.0007290413,0.0003193092,0.0001975271,0.0003562177,0.0002064109,0.01180761],"genre_scores_gemma":[0.9828728,0.01246977,0.0007649902,0.0002422632,0.00009296106,0.00004772592,0.0002798945,0.00001426555,0.003215353],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001466141,"threshold_uncertainty_score":0.004904807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003316205","doi":"10.1358/dot.2010.46.2.1464700","title":"Saxagliptin in type 2 diabetes","year":2010,"lang":"en","type":"article","venue":"Drugs of today","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Saxagliptin; Medicine; Glycemic; Metformin; Incretin; Type 2 diabetes; Hypoglycemia; Pharmacology; Diabetes mellitus; Internal medicine; Sitagliptin; Endocrinology","authors":[{"name":"Raquel Billiones","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006862667400269849,"gpt":0.2439676717201539,"spread":0.2371050043198841,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006579126,0.000408142,0.0006673943,0.0004702953,0.000221221,0.0005115687,0.0002389376,0.001148672,0.006998674],"category_scores_gemma":[0.0007600489,0.00008224064,0.000264263,0.0006375019,0.0002631633,0.0004281125,0.0004808094,0.002144942,0.004380872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003325542,"about_ca_system_score_gemma":0.000603042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005433643,"about_ca_topic_score_gemma":0.0008638469,"domain_scores_codex":[0.9998173,0.0000549917,0.00001987753,0.00002084172,0.00006656998,0.00002039999],"domain_scores_gemma":[0.999743,0.00009703776,0.00003685671,0.00001363133,0.00004869087,0.00006071153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007587585,0.0002166336,0.0009031458,0.001242977,0.00005540588,0.0008619527,0.00006648897,0.0002566799,0.001399954,0.01165943,0.1132276,0.8693509],"study_design_scores_gemma":[0.0004147993,0.0005279265,0.003276327,0.001033945,0.0001033733,0.002942731,0.00003332173,0.0002458173,0.0005211178,0.007666869,0.9832202,0.00001355581],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004210303,0.9183326,0.0015902,0.017789,0.006697517,0.00003941014,0.0001756337,0.00008035461,0.05108484],"genre_scores_gemma":[0.03892587,0.8888574,0.0033017,0.02069163,0.01337077,0.0001144419,0.0006229596,0.00002878342,0.03408656],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006998674,"threshold_uncertainty_score":0.02341294,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117178293","doi":"10.1358/dot.2004.40.11.872578","title":"Efalizumab: Advancing psoriasis management with a novel, targetedT-cell modulator","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Psoriasis; Medicine; Pathogenesis; Monoclonal antibody; Immunology; Clinical trial; Monoclonal; Dermatology; Antibody; Plaque psoriasis; Pathology","authors":[{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01323569622806394,"gpt":0.2490423389269608,"spread":0.2358066426988968,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005817658,0.000921219,0.001243486,0.00218985,0.0002842094,0.000969286,0.0007883331,0.001359063,0.003223264],"category_scores_gemma":[0.0003302223,0.0002549634,0.000450101,0.001930578,0.0003601233,0.001314391,0.0005995078,0.00183467,0.002909655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007574672,"about_ca_system_score_gemma":0.0006887521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008749328,"about_ca_topic_score_gemma":0.001908788,"domain_scores_codex":[0.9998031,0.0000313437,0.00002493439,0.00003020775,0.00008965904,0.00002078222],"domain_scores_gemma":[0.9998778,0.00003625166,0.00002720043,0.000005238499,0.00003406948,0.00001942837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008505301,0.0001042929,0.0001260083,0.004897981,0.00004757283,0.0003750976,0.00003871334,0.0002902443,0.004205048,0.002110384,0.01671439,0.9710053],"study_design_scores_gemma":[0.00006678345,0.0001585692,0.0009542983,0.001578374,0.00005726767,0.003645249,0.00004369143,0.000161784,0.001150614,0.001359678,0.9908075,0.00001608382],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002426208,0.9978707,0.0002720747,0.0003649589,0.0001998092,0.000007343944,0.000009471062,0.00001455277,0.001018497],"genre_scores_gemma":[0.001147575,0.9964684,0.0005823078,0.0003072727,0.0002288224,0.000009984377,0.00002273289,0.000002283004,0.001230547],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003223264,"threshold_uncertainty_score":0.0107829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2339145532","doi":"10.1358/dot.2015.51.10.2401004","title":"Tavaborole topical solution, 5% for the treatment of toenailonychomycosis","year":2015,"lang":"en","type":"review","venue":"Drugs of today","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Trichophyton rubrum; Erythema; Nail (fastener); Clinical trial; Adverse effect; Antifungal; Dermatophyte; Internal medicine","authors":[{"name":"Lee T. Zane","is_ca":false},{"name":"J. J. PLATTNER","is_ca":false},{"name":"Sanjay Chanda","is_ca":false},{"name":"Dina Coronado","is_ca":false},{"name":"Tejal Merchant","is_ca":false},{"name":"Aditya K. Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06903558764533257,"gpt":0.3846905140682847,"spread":0.3156549264229521,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003499467,0.0006757092,0.001116478,0.003181682,0.0002658815,0.0006122601,0.0006307764,0.0006816721,0.004436098],"category_scores_gemma":[0.0004039131,0.0002567268,0.0008497422,0.001925873,0.0002476632,0.0007174511,0.0004545336,0.0009746575,0.001292768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000332186,"about_ca_system_score_gemma":0.0007334715,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0013426,"about_ca_topic_score_gemma":0.003108559,"domain_scores_codex":[0.9998435,0.00002721151,0.00003133618,0.0000242138,0.00005926113,0.0000145029],"domain_scores_gemma":[0.9998602,0.0000594076,0.00003331317,0.00000389347,0.00003166058,0.00001156561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001730807,0.0001434634,0.0001997952,0.05032733,0.0002689738,0.0003346508,0.00008112224,0.0002462687,0.003466005,0.001222624,0.01727604,0.9262607],"study_design_scores_gemma":[0.0001100893,0.000331326,0.002843477,0.01188049,0.0008586475,0.004296594,0.0001232874,0.000160427,0.002139533,0.001004872,0.9762162,0.00003513583],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003217614,0.998688,0.00006803481,0.00006759657,0.00004931009,0.000009779849,0.00002585333,0.000008310989,0.0007613301],"genre_scores_gemma":[0.001945506,0.9971693,0.0001866172,0.000095148,0.00003278529,0.00001058767,0.00004727565,0.000001778937,0.0005110087],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004436098,"threshold_uncertainty_score":0.01484025,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029669980","doi":"10.1358/dot.2009.45.1.1315920","title":"Strategies to preserve prostate health","year":2009,"lang":"en","type":"review","venue":"Drugs of today","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostate cancer; Prostatitis; Prostate Diseases; Clinical trial; Prostate; Etiology; Prostate disease; Intensive care medicine; Bioinformatics; Cancer; Pathology; Internal medicine","authors":[{"name":"Mischel G. Neill","is_ca":true},{"name":"Sree Appu","is_ca":false},{"name":"Alexandre R. Zlotta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04537611585843949,"gpt":0.3922815173844368,"spread":0.3469054015259973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005467304,0.001029158,0.001357111,0.002237533,0.0003538322,0.0008500532,0.000880214,0.001465301,0.006403603],"category_scores_gemma":[0.0006731251,0.0002658336,0.0006372802,0.001265065,0.0005398965,0.001451095,0.0007327491,0.002082304,0.00316717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005088935,"about_ca_system_score_gemma":0.001170999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001071956,"about_ca_topic_score_gemma":0.002404413,"domain_scores_codex":[0.9997595,0.00005817907,0.00003127193,0.00003877576,0.00008639003,0.00002594661],"domain_scores_gemma":[0.9997995,0.00008863672,0.00003866285,0.00001278823,0.00004177015,0.00001868832],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005630194,0.000143342,0.0001777618,0.02192516,0.0001809195,0.0002467477,0.0001038063,0.0003597447,0.002696726,0.008896571,0.03040605,0.9348069],"study_design_scores_gemma":[0.00002862079,0.00009231875,0.0009158883,0.006077963,0.0001214206,0.001402985,0.00009769009,0.00005438673,0.0006412037,0.003148418,0.9874028,0.00001634566],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001473331,0.9958835,0.0003963873,0.0007819089,0.0002986073,0.00001283123,0.0000236869,0.00001959098,0.002436159],"genre_scores_gemma":[0.001104282,0.9961849,0.0007438486,0.0006341971,0.0001721313,0.00001657631,0.00004289296,0.00000265574,0.00109849],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006403603,"threshold_uncertainty_score":0.02142215,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2398096896","doi":"10.1358/dot.2015.51.12.2420391","title":"Patiromer: A significant advance in the management of hyperkalemia","year":2015,"lang":"en","type":"review","venue":"Drugs of today","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Hyperkalemia; Medicine; Spironolactone; Kidney disease; Heart failure; Aldosterone; Adverse effect; Internal medicine; Urology","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02952100010733287,"gpt":0.3355143980820784,"spread":0.3059933979747455,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005052437,0.0006862358,0.001001243,0.002743929,0.0002423093,0.0007855401,0.0006643688,0.0008616655,0.003393942],"category_scores_gemma":[0.0006313421,0.000215554,0.0006694149,0.001616381,0.0004594106,0.001291004,0.0007105451,0.002531983,0.001653459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004589995,"about_ca_system_score_gemma":0.0008141435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009179591,"about_ca_topic_score_gemma":0.0020657,"domain_scores_codex":[0.9997796,0.00003341842,0.00004391441,0.00004214826,0.00008009273,0.00002088776],"domain_scores_gemma":[0.9996701,0.0001439589,0.00005434355,0.000009483129,0.00008946023,0.00003252809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000927826,0.0001070028,0.0002507659,0.01272427,0.00009486999,0.0002579217,0.00005966212,0.0002035934,0.001171057,0.002235553,0.02090701,0.9618954],"study_design_scores_gemma":[0.00004868602,0.0001568672,0.001538776,0.003847987,0.0001217189,0.003669361,0.00005836736,0.00009962769,0.0005286267,0.00147944,0.988425,0.00002557272],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001448157,0.9982911,0.0001062448,0.0003296093,0.0001480283,0.000003869465,0.00001256037,0.000009818952,0.0009539663],"genre_scores_gemma":[0.001169385,0.9975774,0.0002066866,0.0003130527,0.0002068617,0.000004093008,0.00003442396,0.000002110485,0.0004860989],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003393942,"threshold_uncertainty_score":0.01135391,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2412549228","doi":"10.1358/dot.2015.51.6.2339112","title":"American Psychiatric Association - 168th Annual Meeting (May 16-20,2015 - Toronto, Canada)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Psychiatry; Association (psychology); Addiction; Theme (computing); Gerontology; Psychotherapist; Psychology","authors":[{"name":"Alexandra Kibble","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01329601164486981,"gpt":0.2968485207447442,"spread":0.2835525090998744,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001280393,0.001072414,0.0007466332,0.001320224,0.003015421,0.00270669,0.001191807,0.002614471,0.3008554],"category_scores_gemma":[0.001642761,0.0004687537,0.0005885763,0.001117058,0.0005172692,0.001006751,0.002124436,0.002821754,0.1483234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007982193,"about_ca_system_score_gemma":0.01956076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3348878,"about_ca_topic_score_gemma":0.7901212,"domain_scores_codex":[0.9991465,0.00005806792,0.00003864128,0.00006673508,0.0003418956,0.0003482509],"domain_scores_gemma":[0.996392,0.00005063906,0.0000753835,0.00004228228,0.00171525,0.001724395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001913127,0.000015485,0.0003704546,0.00003930434,0.000002976893,0.00002400972,0.00001202553,0.00001334604,0.00005239377,0.0000800725,0.9851117,0.01425922],"study_design_scores_gemma":[0.00001629898,0.00002107777,0.007805169,0.0002397886,0.000005040174,0.00005823702,0.0001474894,0.00004531591,0.00003560358,0.00008535709,0.9915299,0.00001062806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.005824341,0.03689219,0.001391021,0.125915,0.1191194,0.001166551,0.02414697,0.001344257,0.6842003],"genre_scores_gemma":[0.006576013,0.01528474,0.0007021099,0.007059662,0.00529854,0.0001902731,0.006907506,0.0001688693,0.9578122],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.3348878,"threshold_uncertainty_score":0.997245,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2321447119","doi":"10.1358/dot.2011.47.6.1603439","title":"Tesamorelin: A novel therapeutic option for HIV/HAART-associatedincreased visceral adipose tissue","year":2011,"lang":"en","type":"article","venue":"Drugs of today","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Adipose tissue; Hormone; Glucose homeostasis; Endocrinology; Internal medicine; Homeostasis; Lipid profile; Obesity; Bioinformatics; Diabetes mellitus; Insulin resistance; Biology","authors":[{"name":"Julian Falutz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03736310445377607,"gpt":0.3154414242656713,"spread":0.2780783198118952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001022326,0.0001793502,0.0002854012,0.00017616,0.0001474111,0.0002235487,0.0001369416,0.0002914045,0.002300859],"category_scores_gemma":[0.00008030688,0.00006679648,0.0002135415,0.0001207606,0.0001379095,0.0002430101,0.0001473052,0.0005180086,0.0005048138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008158854,"about_ca_system_score_gemma":0.00009584762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008156629,"about_ca_topic_score_gemma":0.0002683966,"domain_scores_codex":[0.9999779,0.000007392493,0.000002069517,0.000003246674,0.000004118511,0.000005259148],"domain_scores_gemma":[0.9999825,0.000005202205,0.000004739011,0.000001148988,0.000001442188,0.000005016264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.009718358,0.001257946,0.00239901,0.00107356,0.0001332772,0.004800315,0.0001761205,0.001156475,0.1406137,0.003911227,0.00741132,0.8273487],"study_design_scores_gemma":[0.02490675,0.05121017,0.0569752,0.0009005455,0.0008756592,0.08556189,0.0006966406,0.01001805,0.168717,0.01148815,0.5884713,0.0001786801],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.769401,0.1824726,0.01028256,0.004494439,0.001165543,0.0003032529,0.0005673898,0.0003972783,0.0309159],"genre_scores_gemma":[0.941882,0.04186479,0.006806679,0.001335288,0.0005370436,0.0001140401,0.0003519746,0.00001792299,0.007090237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002300859,"threshold_uncertainty_score":0.007697165,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3120200411","doi":"10.1358/dot.2021.57.1.3233361","title":"Recombinant vesicular stomatitis virus expressing Ebola virusglycoprotein (rVSV-EBOV), a new Ebola vaccine","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women and Children’s Health Research Institute; University of Alberta","funders":"","keywords":"Ebola vaccine; Ebola virus; Virology; Vesicular stomatitis virus; Ebolavirus; Sierra leone; Outbreak; Medicine; Vaccination; Virus","authors":[{"name":"Zubia Mumtaz","is_ca":true},{"name":"Michael Hawkes","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01607867106629849,"gpt":0.2971816121544201,"spread":0.2811029410881216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003449198,0.0001739071,0.0002548895,0.0001982673,0.00009053687,0.0002357334,0.0001538877,0.0002861098,0.001412632],"category_scores_gemma":[0.000168236,0.00007398376,0.0001588619,0.00008871945,0.0001690283,0.0002064514,0.0001637188,0.0004370265,0.0003942371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002536945,"about_ca_system_score_gemma":0.0003318058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005353767,"about_ca_topic_score_gemma":0.0007989789,"domain_scores_codex":[0.9999076,0.00002764681,0.000006838961,0.00001334353,0.00002891732,0.00001567187],"domain_scores_gemma":[0.9999638,0.000004902635,0.00001040626,0.00000346428,0.000006431162,0.00001112119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005302232,0.002225595,0.007480623,0.0009896638,0.0001553227,0.0005756509,0.0001417631,0.001191162,0.6851591,0.004952568,0.01553731,0.276289],"study_design_scores_gemma":[0.00592286,0.0404635,0.04521457,0.0005749912,0.0004843554,0.006525829,0.0002457667,0.003731175,0.4332602,0.001858921,0.4616407,0.00007705182],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9215739,0.04830281,0.008035836,0.002856795,0.00118832,0.0006546875,0.001811724,0.0004164556,0.01515947],"genre_scores_gemma":[0.9678269,0.01209651,0.007293903,0.0007799214,0.0001878111,0.0002228218,0.00180674,0.0000166505,0.009768567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001412632,"threshold_uncertainty_score":0.004725695,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002072862","doi":"10.1358/dot.2006.42.9.996568","title":"Ropinirole treatment for restless legs syndrome","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Ropinirole; Restless legs syndrome; Medicine; Selegiline; Levodopa; Pramipexole; Placebo; Dopaminergic; Rotigotine; Population; Dopamine agonist; Dopamine; Pharmacology; Internal medicine; Parkinson's disease; Insomnia; Alternative medicine; Disease","authors":[{"name":"Miklos Z. Molnar","is_ca":false},{"name":"Katalin Fornadi","is_ca":false},{"name":"Colin M. Shapiro","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1143577149302418,"gpt":0.4339965283323711,"spread":0.3196388134021293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003217612,0.0007192426,0.001272741,0.002171155,0.0002797532,0.0004456363,0.0005641954,0.0008972372,0.004407934],"category_scores_gemma":[0.0003571211,0.0001640596,0.000499566,0.001479545,0.0002285171,0.0007381014,0.0002902671,0.0008298612,0.001391412],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002793076,"about_ca_system_score_gemma":0.0004209489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005408806,"about_ca_topic_score_gemma":0.001204394,"domain_scores_codex":[0.9998817,0.00002913342,0.00001898284,0.0000213464,0.00003668252,0.00001210134],"domain_scores_gemma":[0.9998678,0.00006770335,0.0000329398,0.000003566452,0.00001667126,0.0000113162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001818717,0.0001112748,0.0001850503,0.01794019,0.0001094943,0.0005728125,0.00007027229,0.0001691092,0.001585934,0.0007637507,0.01484772,0.9634627],"study_design_scores_gemma":[0.0002549181,0.000688902,0.003857188,0.008788389,0.0005377443,0.01095508,0.0001755225,0.0002220119,0.001995897,0.00125007,0.9712377,0.00003648777],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002668629,0.9987291,0.00005404571,0.00009926157,0.0001043601,0.000007065139,0.000006746697,0.000006244639,0.0007264584],"genre_scores_gemma":[0.002053959,0.9966003,0.0001630065,0.0001826481,0.000181037,0.00001428642,0.00002446283,0.000001653975,0.0007787573],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004407934,"threshold_uncertainty_score":0.01474601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282918298","doi":"10.1358/dot.2022.58.6.3400572","title":"Bimekizumab for psoriasis","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Psoriasis; Ustekinumab; Tolerability; Adalimumab; Adverse effect; Dermatology; Immunology; Immune system; Population; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis","authors":[{"name":"Maria Alexandra Rodrigues","is_ca":false},{"name":"Egídio Freitas","is_ca":false},{"name":"Tiago Torres","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01460619210585043,"gpt":0.24055590479578,"spread":0.2259497126899296,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004047719,0.000438864,0.000426607,0.0004413268,0.0003494864,0.0005312691,0.0003094828,0.001048674,0.02028631],"category_scores_gemma":[0.0005105438,0.00007717156,0.0005009832,0.0002434442,0.0001729531,0.0004498784,0.0005087388,0.002100772,0.0111667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003984194,"about_ca_system_score_gemma":0.000450217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001795485,"about_ca_topic_score_gemma":0.0004504085,"domain_scores_codex":[0.9998192,0.00003093687,0.00001430282,0.00002817775,0.00006953923,0.00003786353],"domain_scores_gemma":[0.9998533,0.00002281642,0.00002400844,0.000008268234,0.00002784781,0.00006377675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005331149,0.0002915748,0.0004118324,0.0008887532,0.00005135854,0.0008423161,0.00003920682,0.0001153143,0.004936821,0.003880175,0.1771059,0.8109037],"study_design_scores_gemma":[0.0005665844,0.0006114419,0.001092579,0.0004563065,0.0000417743,0.004912429,0.00001674744,0.0001684226,0.001513617,0.0027935,0.9878154,0.00001132153],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0155751,0.7783365,0.004332958,0.04261348,0.01648116,0.0003141126,0.0006732831,0.00095428,0.1407192],"genre_scores_gemma":[0.1643677,0.4517857,0.01024035,0.07384626,0.02709869,0.0004101796,0.002330655,0.0002470391,0.2696734],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02028631,"threshold_uncertainty_score":0.06786448,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210789185","doi":"10.1358/dot.2022.58.1.3353167","title":"Estetrol and drospirenone: a novel oral contraceptive","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Drospirenone; Estrogen; Endocrine system; Estrogen receptor; Endometrial cancer; Agonist; Pharmacology; Endometrium; Internal medicine; Endocrinology; Gynecology; Physiology; Receptor; Cancer; Hormone; Breast cancer","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01420952329394259,"gpt":0.279956472327496,"spread":0.2657469490335534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001357822,0.0003312123,0.0002500866,0.0006047964,0.0001702083,0.0003337904,0.000243097,0.0004703565,0.003524706],"category_scores_gemma":[0.000160719,0.0001184105,0.0002585699,0.0002380793,0.0002011217,0.0003143318,0.00024992,0.0007035838,0.001332815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001262866,"about_ca_system_score_gemma":0.0001418601,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002540118,"about_ca_topic_score_gemma":0.0005873106,"domain_scores_codex":[0.9999237,0.000013312,0.00000695722,0.00001660089,0.00002876223,0.00001069167],"domain_scores_gemma":[0.9999717,0.000004587362,0.000007403382,0.000001514882,0.000005041778,0.000009700245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006915346,0.0003607228,0.001028705,0.001958203,0.0000975936,0.002872986,0.00009249604,0.0003341314,0.06672525,0.008320719,0.02228812,0.8952296],"study_design_scores_gemma":[0.0004073057,0.001736515,0.002849445,0.0003098151,0.0000944317,0.01283904,0.0000451052,0.0005723474,0.01981482,0.001641943,0.9596364,0.00005282489],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.03900099,0.9094982,0.004973264,0.004036102,0.001657846,0.0001552676,0.0005584256,0.000247557,0.03987235],"genre_scores_gemma":[0.2257442,0.7119532,0.009122063,0.00486556,0.003109465,0.0002179453,0.001140719,0.00002944477,0.04381732],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.003524706,"threshold_uncertainty_score":0.01179135,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3189922281","doi":"10.1358/dot.2021.57.8.3293588","title":"Vibegron: a beta3-adrenergic agonist for the treatment ofoveractive bladder","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Nocturia; Medicine; Overactive bladder; Anticholinergic; Agonist; Oxybutynin; Urology; Urinary urgency; Urinary incontinence; Anticholinergic agents; Urinary bladder; Adrenergic; Urinary system; Mirabegron; Internal medicine; Receptor; Pathology","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02997721073690499,"gpt":0.3314776276383604,"spread":0.3015004169014553,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001774718,0.0003742381,0.0006285623,0.0003551599,0.0002932014,0.000534841,0.0004845201,0.001095016,0.008532512],"category_scores_gemma":[0.0002281468,0.0001376204,0.0005007297,0.000366024,0.0002174984,0.0003030144,0.0003409967,0.002295817,0.003355386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003048408,"about_ca_system_score_gemma":0.0005226296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007265055,"about_ca_topic_score_gemma":0.001921079,"domain_scores_codex":[0.999881,0.00003023852,0.00000568217,0.00001550078,0.00003406335,0.00003338969],"domain_scores_gemma":[0.9999059,0.00001325536,0.0000159981,0.000005562785,0.0000113649,0.00004788938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008281127,0.002000468,0.002216227,0.003229262,0.0003612092,0.002898015,0.0001513769,0.0008278544,0.1031365,0.003460936,0.09066765,0.7827694],"study_design_scores_gemma":[0.008850905,0.01241193,0.01805745,0.001847549,0.0004031459,0.01788139,0.0001639603,0.001338185,0.05424214,0.00181093,0.8828755,0.0001168877],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2199187,0.5939528,0.008232647,0.01605597,0.004749223,0.001032668,0.008004622,0.002163358,0.14589],"genre_scores_gemma":[0.6289076,0.2336103,0.01080569,0.01635538,0.001054961,0.0005910023,0.01111878,0.0002526751,0.09730363],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.008532512,"threshold_uncertainty_score":0.02854413,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804667058","doi":"10.1358/dot.2018.54.4.2795154","title":"Daclatasvir, asunaprevir and beclabuvir fixed-dose combination forpatients with genotype 1 chronic hepatitis C","year":2018,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Infectious Diseases Centre","funders":"","keywords":"Daclatasvir; Medicine; Internal medicine; Hepatitis C; Regimen; Hepatitis C virus; Virology; Adverse effect; Gastroenterology; Virus; Ribavirin","authors":[{"name":"Astou Thiam","is_ca":true},{"name":"Brian Conway","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03751225994869992,"gpt":0.3483131464482414,"spread":0.3108008864995414,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004569847,0.0006007382,0.001314483,0.002307012,0.0002567253,0.0005827298,0.0006802286,0.0006954829,0.005012533],"category_scores_gemma":[0.000689465,0.00017211,0.0006756239,0.001956131,0.0002970021,0.0007208119,0.0004877581,0.001215724,0.001988286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003388956,"about_ca_system_score_gemma":0.0007683244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009472214,"about_ca_topic_score_gemma":0.00209836,"domain_scores_codex":[0.9998038,0.00004566395,0.0000325474,0.00002818705,0.00007436716,0.00001537103],"domain_scores_gemma":[0.9997332,0.00013213,0.00005372149,0.000008466683,0.00005248029,0.00002007368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009627588,0.00005309031,0.0001233551,0.02651192,0.0001472686,0.0001157484,0.00004018485,0.0001068951,0.0006731455,0.0008804253,0.02154495,0.9497067],"study_design_scores_gemma":[0.00008835477,0.0001634386,0.001488097,0.01019503,0.0004799248,0.002295144,0.0000742313,0.00009050743,0.0004517306,0.0009335689,0.9837203,0.00001964099],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000104378,0.9990559,0.00003641982,0.000111849,0.00007025522,0.000005862963,0.00001600932,0.00000534353,0.0005939844],"genre_scores_gemma":[0.0007858667,0.9984951,0.0001075541,0.0001045931,0.00006113662,0.000006770857,0.00002906007,0.000001056142,0.0004087764],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005012533,"threshold_uncertainty_score":0.01676863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119281289","doi":"10.1358/dot.2021.57.1.3211618","title":"Apomorphine hydrochloride: A sublingual tablet for the OFF episodesin Parkinson's disease","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Apomorphine; Levodopa; Parkinson's disease; Disease; Pediatrics; Anesthesia; Dopamine; Internal medicine; Dopaminergic","authors":[{"name":"David M. Paton","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01834182986100732,"gpt":0.2748438631171107,"spread":0.2565020332561034,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005797788,0.0001954854,0.0002360586,0.000237954,0.0001697644,0.0001039262,0.000160723,0.0003281222,0.002185679],"category_scores_gemma":[0.00009100846,0.00006083288,0.0001275524,0.00008397658,0.00009217012,0.0001414252,0.0001111419,0.0005758621,0.0006009718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008517576,"about_ca_system_score_gemma":0.000126512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005528324,"about_ca_topic_score_gemma":0.00264882,"domain_scores_codex":[0.9999756,0.000003972848,0.000001698399,0.000004407434,0.00001001412,0.000004431314],"domain_scores_gemma":[0.9999769,0.000003065326,0.000004077763,0.000001208038,0.000002596254,0.00001220394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005374602,0.002866237,0.002025592,0.0009751787,0.00009946974,0.004555835,0.0002701802,0.000208601,0.2104542,0.001237985,0.02210394,0.7498282],"study_design_scores_gemma":[0.01901364,0.07347718,0.2126018,0.0007020936,0.0004056652,0.05643915,0.0005393134,0.005329209,0.1400259,0.001598809,0.4896901,0.0001773963],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9081858,0.04870528,0.004179573,0.003410848,0.0006175288,0.0005694196,0.0008133493,0.000894221,0.03262405],"genre_scores_gemma":[0.9590529,0.01521927,0.0031661,0.001384486,0.0002302617,0.0001264303,0.000372601,0.00002999848,0.02041806],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002185679,"threshold_uncertainty_score":0.007311821,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246551118","doi":"10.1358/dot.2015.051.06.2339112","title":"American Psychiatric Association - 168th Annual Meeting (May 16-20, 2015 - Toronto, Canada)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Association (psychology); Psychiatry; Family medicine; Environmental health","authors":[{"name":"Angel Kibble","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006765480933943373,"gpt":0.2606537743979496,"spread":0.2538882934640062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001546877,0.001084939,0.000883263,0.0013089,0.00336864,0.002752198,0.001121938,0.003089251,0.2676264],"category_scores_gemma":[0.001800623,0.0005144998,0.0007417716,0.0009830559,0.0005994667,0.000832839,0.001825188,0.00280116,0.120881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007020267,"about_ca_system_score_gemma":0.01916265,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3512424,"about_ca_topic_score_gemma":0.8116472,"domain_scores_codex":[0.9990395,0.0000604475,0.00004294913,0.00006394998,0.0004351597,0.0003578987],"domain_scores_gemma":[0.9961793,0.00006640238,0.00008305967,0.00004721575,0.002256863,0.001367148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005333298,0.00002575632,0.000646856,0.00005808984,0.000007922335,0.00003784183,0.00001103308,0.00002342719,0.0001066572,0.00008341897,0.9796808,0.0192649],"study_design_scores_gemma":[0.00004412621,0.00005294539,0.01873296,0.0003607488,0.00002010443,0.0001189017,0.0001664112,0.00008019562,0.0001127634,0.0001298269,0.9801638,0.00001724491],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.009185758,0.04878299,0.001188007,0.1161484,0.1136567,0.0009883658,0.02101192,0.001116015,0.6879219],"genre_scores_gemma":[0.008452018,0.0148559,0.0008236067,0.005274635,0.004304748,0.0001147721,0.006640397,0.0001289882,0.9594048],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.6487576,"threshold_uncertainty_score":0.8952995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2410968598","doi":"10.1358/dot.2004.40.7.850479","title":"Recent developments in lipid-lowering therapy - Highlights from theAtorvastatin Landmark Program: Global Investigators Meeting III","year":2004,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Landmark; Guideline; Clinical trial; Clinical Practice; Modalities; Medical physics; Family medicine; Pharmacology; Pathology; Artificial intelligence; Computer science","authors":[{"name":"Prabirkumar Bandyopadhyay","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01544992483414326,"gpt":0.2747528325590962,"spread":0.2593029077249529,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006700213,0.0006132076,0.0007075112,0.0009572383,0.0004118118,0.002359693,0.001025195,0.003201645,0.003231752],"category_scores_gemma":[0.003946535,0.0002621246,0.0006542802,0.001544852,0.0005210986,0.001043957,0.0009623579,0.003229587,0.001036724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002070411,"about_ca_system_score_gemma":0.005013264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002980605,"about_ca_topic_score_gemma":0.01474802,"domain_scores_codex":[0.9987468,0.0004384208,0.0001280133,0.00009347123,0.0003740083,0.0002194094],"domain_scores_gemma":[0.9957554,0.0009051876,0.0004000567,0.00006491168,0.001635528,0.001239025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001560453,0.0001672395,0.003072161,0.002926585,0.0001129864,0.0005138383,0.0001702583,0.0003906897,0.002192029,0.003432757,0.6952835,0.2901775],"study_design_scores_gemma":[0.000301371,0.0005296038,0.0103857,0.001382675,0.0002538556,0.0006257705,0.0001896964,0.0002197882,0.00097873,0.001283543,0.9838122,0.00003723588],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007636043,0.5581957,0.0019222,0.3677076,0.04903015,0.0001851901,0.0007983169,0.0001247067,0.01440011],"genre_scores_gemma":[0.06460457,0.5839089,0.01156967,0.1457652,0.1495925,0.0004094522,0.002828981,0.0001552054,0.04116561],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006700213,"threshold_uncertainty_score":0.03543454,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2327987781","doi":"10.1358/dot.2014.50.1.2118308","title":"A report from the 16th IGPA conference (December 9-11, 2013 -Brussels, Belgium)","year":2014,"lang":"en","type":"article","venue":"Drugs of today","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Alliance; Medicine; Negotiation; Member states; Economic growth; International trade; Political science; Business; Law","authors":[{"name":"Mary Jean Bowman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04266725827465574,"gpt":0.2673820248804933,"spread":0.2247147666058376,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004975792,0.001383194,0.0007300896,0.001980489,0.002157109,0.008237376,0.001522885,0.004207215,0.1236118],"category_scores_gemma":[0.007170246,0.0004574365,0.001080565,0.002075469,0.0006217904,0.002464819,0.002566258,0.003967935,0.05206862],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004101135,"about_ca_system_score_gemma":0.009297179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02705677,"about_ca_topic_score_gemma":0.0363418,"domain_scores_codex":[0.9970061,0.00041494,0.00008555311,0.0002620818,0.00145456,0.0007768205],"domain_scores_gemma":[0.9943876,0.0005319121,0.000247714,0.0001633736,0.002830449,0.001838918],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006188677,0.00003864754,0.0002441377,0.0001133498,0.000005325104,0.00006526343,0.00004374248,0.00007377493,0.0001126052,0.0003815558,0.9885566,0.01030302],"study_design_scores_gemma":[0.00001348205,0.0000309302,0.00251807,0.0001907705,0.000007524609,0.0000381114,0.0002579832,0.00006810419,0.0001839669,0.000209489,0.9964674,0.0000141719],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.01247135,0.05798961,0.005672843,0.1837581,0.3257062,0.001738467,0.0365429,0.001570851,0.3745497],"genre_scores_gemma":[0.02618415,0.02039072,0.00450572,0.01844434,0.0278609,0.001006993,0.02043102,0.001018871,0.8801572],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1236118,"threshold_uncertainty_score":0.4135228,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2442538157","doi":"10.1358/dot.2015.51.5.2336329","title":"A report from the American Association of Urology Annual Meeting2015 (May 15-19 - New Orleans, Louisiana, USA)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Convention; Quarter (Canadian coin); Gerontology; Family medicine; Library science; Archaeology","authors":[{"name":"X Rabasseda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01935715254727123,"gpt":0.3010949530022958,"spread":0.2817378004550246,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00514728,0.001169846,0.0006276389,0.002855988,0.001769714,0.004237603,0.001129921,0.00271365,0.1091266],"category_scores_gemma":[0.005413037,0.0003725068,0.0009050063,0.001836811,0.0003462798,0.001595866,0.002315222,0.002525314,0.0424988],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002841837,"about_ca_system_score_gemma":0.01000654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0162236,"about_ca_topic_score_gemma":0.03241779,"domain_scores_codex":[0.9974459,0.000270243,0.0001585805,0.0001701653,0.001493655,0.0004613317],"domain_scores_gemma":[0.9907279,0.000333765,0.0003637588,0.0001589334,0.0064322,0.001983418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000342598,0.00004471184,0.000607756,0.0001447142,0.000008314769,0.0000360093,0.00001898608,0.00002286238,0.0001328827,0.0001131747,0.9769301,0.0219061],"study_design_scores_gemma":[0.000009696699,0.00004331814,0.004039515,0.0002619991,0.00001187003,0.00004502086,0.000116388,0.00003892761,0.0001893568,0.00008169439,0.99515,0.00001226118],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"review","genre_scores_codex":[0.008132691,0.05906725,0.0033046,0.2023597,0.4643947,0.002041344,0.03810361,0.001070556,0.2215255],"genre_scores_gemma":[0.02164466,0.04027336,0.003189344,0.03811311,0.05271769,0.001054748,0.03587918,0.0004756849,0.8066522],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.1091266,"threshold_uncertainty_score":0.3650649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2334764107","doi":"10.1358/dot.2013.49.9.2056599","title":"A report from the European Society of Cardiology Congress 2013(August 31-September 4, 2013 - Amsterdam, The Netherlands)","year":2013,"lang":"en","type":"article","venue":"Drugs of today","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Attendance; Session (web analytics); Canadian Cardiovascular Society; Convention; Alternative medicine; Medical education; Preclinical research; Family medicine; Medical physics; Internal medicine; Myocardial infarction; Pathology; Law; Political science","authors":[{"name":"X Rabasseda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01110543531327187,"gpt":0.2360079853277723,"spread":0.2249025500145004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004344232,0.001215992,0.0007222043,0.003188751,0.001056439,0.004562072,0.0009524122,0.002887384,0.07487299],"category_scores_gemma":[0.005242772,0.0004005947,0.0009250265,0.003151982,0.0003317831,0.001485811,0.001868797,0.002648477,0.03884877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002103835,"about_ca_system_score_gemma":0.006597762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01244381,"about_ca_topic_score_gemma":0.01637722,"domain_scores_codex":[0.9976041,0.0002072436,0.0002029019,0.0001633796,0.001451414,0.000371029],"domain_scores_gemma":[0.9949105,0.0003607437,0.0003755536,0.0001319853,0.003063504,0.001157774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006481752,0.00004015035,0.0005958767,0.0002426492,0.00001199216,0.0001038992,0.00003544412,0.0000434531,0.0001413608,0.0002109558,0.9770621,0.02144736],"study_design_scores_gemma":[0.00001926372,0.00004975284,0.006288287,0.0003466829,0.00002207095,0.0001045955,0.0001614837,0.00004379586,0.0002857222,0.0001369119,0.9925213,0.00002008453],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"commentary","genre_scores_codex":[0.01168506,0.09448683,0.003710905,0.1663896,0.3599197,0.002012589,0.0881017,0.001307903,0.2723857],"genre_scores_gemma":[0.04066578,0.09616295,0.004749637,0.03718906,0.07723625,0.001683726,0.07665301,0.001015643,0.6646439],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.07487299,"threshold_uncertainty_score":0.2504752,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2526768593","doi":"10.1358/dot.2017.53.6.2662982","title":"Notable deals in the pharmaceutical industry in the first quarterof 2017","year":2017,"lang":"en","type":"review","venue":"Drugs of today","topic":"Competitive and Knowledge Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine; Pharmaceutical industry","authors":[{"name":"E Cruces","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.171942251902463,"gpt":0.4050399365276934,"spread":0.2330976846252304,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008925055,0.000574119,0.00050563,0.003709695,0.0004595453,0.002964239,0.000486429,0.0009368958,0.005924309],"category_scores_gemma":[0.001647326,0.0002433338,0.0004562739,0.006515613,0.0004340287,0.001931661,0.001099822,0.001115505,0.001944418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001474681,"about_ca_system_score_gemma":0.002456496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003303969,"about_ca_topic_score_gemma":0.009615022,"domain_scores_codex":[0.9993162,0.00008665672,0.00007435442,0.00007152941,0.0003772206,0.00007402937],"domain_scores_gemma":[0.9992482,0.0002118113,0.0002506978,0.00001351814,0.0002124692,0.00006323369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008218084,0.00004909357,0.001331017,0.01351194,0.00008102225,0.0002923093,0.0002411868,0.000187149,0.0008026529,0.006100066,0.03698759,0.9403337],"study_design_scores_gemma":[0.00000705942,0.00005699764,0.004293167,0.005059521,0.00009720391,0.0008959665,0.0002620951,0.00005177523,0.0005089984,0.0007410754,0.9880098,0.00001638134],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001232372,0.989692,0.00008224654,0.0008700961,0.000283129,0.0000136918,0.0001470505,0.00001188994,0.007667493],"genre_scores_gemma":[0.006264821,0.9901272,0.000143211,0.0004364641,0.0002200987,0.000007817591,0.0001935944,0.00000316624,0.002603618],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005924309,"threshold_uncertainty_score":0.01981878,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253960987","doi":"10.1358/dot.2016.52.10.2560079","title":"Notable deals in the pharmaceutical industry in the third quarterof 2016","year":2016,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Pharmaceutical industry; Pharmacology","authors":[{"name":"E Cruces","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01796769573493584,"gpt":0.304380711128217,"spread":0.2864130153932811,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002134084,0.0003933395,0.0002756061,0.002561718,0.001438151,0.006718626,0.0003964015,0.001124479,0.008789172],"category_scores_gemma":[0.004481538,0.0002499769,0.0004256982,0.003960977,0.0008633228,0.002150686,0.002066537,0.001294855,0.003132609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003127889,"about_ca_system_score_gemma":0.001881847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00397554,"about_ca_topic_score_gemma":0.008535238,"domain_scores_codex":[0.9977069,0.0001364567,0.0001056494,0.0001437701,0.001542557,0.0003647003],"domain_scores_gemma":[0.9966797,0.0004487315,0.001240685,0.0001437873,0.0007758706,0.0007113243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000799895,0.0002861652,0.1315859,0.001110204,0.00009917562,0.003569805,0.007171768,0.000795523,0.01462887,0.0673352,0.2528592,0.5197584],"study_design_scores_gemma":[0.00001764807,0.0001419671,0.1750264,0.000263188,0.00002217103,0.001588718,0.002259545,0.0004334864,0.004390227,0.001465596,0.8143533,0.00003766786],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.514662,0.04439362,0.001693167,0.01828383,0.003997146,0.0002282694,0.005771173,0.0004583606,0.4105125],"genre_scores_gemma":[0.7232426,0.02578207,0.001534956,0.003361902,0.003039538,0.00008336331,0.006334856,0.0001538624,0.2364668],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.008789172,"threshold_uncertainty_score":0.02940273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252160329","doi":"10.1358/dot.2017.53.10.2746403","title":"Notable licensing deals in the biopharma industry in the thirdquarter of 2017","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Mergers and acquisitions; Pharmaceutical industry; Pharmacology; Finance; Business","authors":[{"name":"P D'Souza","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0631181787243877,"gpt":0.3970966101145358,"spread":0.3339784313901481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003109836,0.0005927868,0.0003418915,0.003591547,0.002558255,0.008109556,0.0007727466,0.002079234,0.04275429],"category_scores_gemma":[0.008317816,0.0004209294,0.0006365979,0.003580168,0.001533496,0.002762623,0.003260901,0.003364497,0.01611894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005309646,"about_ca_system_score_gemma":0.006386311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01260552,"about_ca_topic_score_gemma":0.02195854,"domain_scores_codex":[0.9951237,0.0002133877,0.0001167221,0.0003843567,0.003366522,0.000795266],"domain_scores_gemma":[0.9886003,0.001977746,0.002008379,0.0005585589,0.003441386,0.003413549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0004197984,0.000166991,0.02180247,0.0003648893,0.0000414159,0.001585154,0.00114411,0.0001760858,0.004895985,0.02908038,0.821357,0.1189656],"study_design_scores_gemma":[0.00003375286,0.0001081746,0.04008614,0.0001132982,0.00001117658,0.0005300127,0.0007004549,0.0001739747,0.002623707,0.0009132283,0.9546787,0.00002744716],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.1068745,0.01218546,0.001936273,0.03718601,0.01063197,0.0004322002,0.006983805,0.002094294,0.8216756],"genre_scores_gemma":[0.2472053,0.006788512,0.0009143914,0.01030941,0.006407634,0.0002099559,0.008159922,0.000557171,0.7194476],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.04275429,"threshold_uncertainty_score":0.1430274,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247809272","doi":"10.1358/dot.2018.54.2.2792548","title":"Life sciences licensing deals in the fourthquarter of 2017: updatesand trends","year":2018,"lang":"en","type":"article","venue":"Drugs of today","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Mergers and acquisitions; Finance; Business","authors":[{"name":"P D'Souza","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1023021727966578,"gpt":0.4182660856357171,"spread":0.3159639128390592,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002725312,0.0005840403,0.0005300461,0.009814162,0.0005964538,0.006647993,0.000923668,0.001325905,0.02048022],"category_scores_gemma":[0.01458002,0.0003788719,0.0006719089,0.01701852,0.00073268,0.006896343,0.001886301,0.002210115,0.008855257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004014987,"about_ca_system_score_gemma":0.004246572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02436824,"about_ca_topic_score_gemma":0.02876612,"domain_scores_codex":[0.9958759,0.000219779,0.0004134499,0.000378364,0.002589164,0.0005233609],"domain_scores_gemma":[0.9718919,0.004161003,0.01048815,0.000449667,0.01059528,0.002414027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004081545,0.0002441601,0.1581811,0.001383212,0.00008813442,0.0002893757,0.000994163,0.0004016711,0.0006603409,0.006143018,0.419851,0.4113558],"study_design_scores_gemma":[0.0000249089,0.00008382607,0.1776039,0.0007051338,0.00005239542,0.0005359272,0.001532086,0.0003725062,0.001148637,0.000497526,0.8174078,0.00003538972],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.3302822,0.2011764,0.002891734,0.07231309,0.01001893,0.000222815,0.1130542,0.001703293,0.2683373],"genre_scores_gemma":[0.4422437,0.2073992,0.003409594,0.01276204,0.0112752,0.0002578945,0.1409986,0.0009167443,0.180737],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02436824,"threshold_uncertainty_score":0.06851315,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}